Quick News Bit

Flu/COVID Co-Infections Potentially More Severe in Kids, CDC Says

0

The CDC warned that co-infections with COVID-19 and influenza can potentially cause more severe illness in children, and need to be tracked.

Surveillance data from the 2021-2022 influenza season revealed that 6% of flu-related hospitalizations and 16% of flu-related deaths involved children co-infected with COVID-19, Katherine Adams, MPH, of the CDC in Atlanta, and colleagues reported.

Of the seven co-infected children who died, none had received the flu shot, although six were eligible, according to the findings in the Morbidity and Mortality Weekly Report.

Co-infected children were more likely to require bilevel positive airway pressure (BiPAP) or continuous positive airway pressure (CPAP) compared with those who only had the flu (16% vs 6%, respectively, P=0.05), and they were also more likely to need invasive mechanical ventilation (13% vs 4%, P=0.03).

Influenza antivirals were underutilized, “particularly among persons aged <18 years with influenza virus and SARS-CoV-2 co-infections who died,” the group wrote, noting that only one of the seven children who died had been given influenza antivirals.

The 2021-2022 influenza season had 44 pediatric deaths attributed to influenza, while to date there have already been 21 pediatric influenza deaths in the current 2022-2023 season.

“These findings represent a small number of cases of influenza and SARS-CoV-2 co-infection, thereby limiting the ability to draw firm conclusions,” the group cautioned, but added that “the high degree of co-circulation of multiple respiratory viruses during the current season, and the higher-than-usual early-season influenza activity, underscore the importance of increasing awareness among parents and providers that influenza and SARS-CoV-2 co-infections occur in pediatric patients and that co-infection can potentially cause more severe illness.”

For pediatric patients with acute respiratory illness symptoms with suspected severe illness, the researchers suggest performing tests for influenza, SARS-CoV-2, and other respiratory viruses to identify when there is more than one infection. This is “critical to facilitate early detection of co-infections and help guide clinical treatment and management,” wrote Adams and colleagues.

The data for their report were gathered from three CDC surveillance systems — including the Influenza Hospitalization Surveillance Network (FluSurv-NET) and the Influenza-Associated Pediatric Mortality Surveillance System — and identified 575 pediatric influenza-associated hospitalizations, including 32 patients who were coinfected with SARS-CoV-2.

The median age of the 32 children hospitalized with co-infection was 3 years (IQR 1-12 years). Four were vaccinated against the flu and 19 were not vaccinated, while five were ineligible.

  • author['full_name']

    Ingrid Hein is a staff writer for MedPage Today covering infectious disease. She has been a medical reporter for more than a decade. Follow

Disclosures

Adams had nothing to disclose. Co-authors reported relationships with Goldbelt Professional Services, General Dynamics Information Technology, Pfizer, Merck, PaxVax, Micron, Sanofi-Pasteur, Janssen, MedImmune, GSK, Sanofi-Pasteur, Kentucky Bioprocessing, WCG, ACI Clinical, the NIH, Michigan Department of Health and Human Services, and the Council of State and Territorial Epidemiologists.

Primary Source

Morbidity and Mortality Weekly Report

Source Reference: Adams K, et al “Prevalence of SARS-CoV-2 and influenza coinfection and clinical characteristics among children and adolescents aged <18 years who were hospitalized or died with influenza — United States, 2021-22 influenza season” MMWR 2022; DOI: 10.15585/mmwr.mm7150a4.

For all the latest Health News Click Here 

 For the latest news and updates, follow us on Google News

Read original article here

Denial of responsibility! NewsBit.us is an automatic aggregator around the global media. All the content are available free on Internet. We have just arranged it in one platform for educational purpose only. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials on our website, please contact us by email – [email protected]. The content will be deleted within 24 hours.

Leave a comment